Additional Details

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

University of Kansas Medical Center
Kansas City, KS 66160
Visit Website Get Directions